Transanal total mesorectal excision versus laparoscopic total mesorectal excision for mid and low rectal cancer (COLOR III): short-term outcomes of an international, multicentre, phase 3, randomised, controlled, non-inferiority trial
{{output}}
Background: Transanal total mesorectal excision (TaTME) facilitates distal pelvic dissection and enables low anastomoses for mid and low rectal cancer, potentially avoiding permanent colostomy. However, its oncological safety rem... ...
